Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Episode 9: Why intense pulsed light therapy is ideal for treating chalazion
In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.
Avedro, Inc., company update: Epi-on crosslinking (CXL) and PiXL technology
ICYMI: Here's what's in the 2019 pipeline
Comparison between aberration neutral and negatively aberrated toric IOLs
ICYMI: Dr. Packer shares the pearls from his 2019 ASCRS presentation
Study: Femtosecond laser-assisted arcuate incisions and plate-haptic toric IOLs
ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!
Validation of defocus tolerance of novel aberration-neutral hydrophobic acrylic monofocal IOL
Eva Liang, MD, discusses the take-home message from her presentation at ASCRS 2019
Management of ocular inflammation and pain using novel insert
ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).
Episode 8: It's time to add IPL therapy to your toolbox
Harvey A. Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy is a valuable asset in any ophthalmologist's toolbox
Comparative study: Femtosecond-assisted grid pattern uses 50% less phaco energy
ICYMI: Dr. Shultz shares the results from a study comparing dual linear venturi phacoemulsification with adaptive fluidics systems using femtosecond-assisted grid pattern versus traditional phaco with horizontal chop
Refractive outcomes soar with wavefront-guided technology system
Robert Maloney, MD, shares how a novel system can assist refractive surgeons
What’s new from Bausch + Lomb for U.S. anterior segment surgeons
Bausch + Lomb provides a company update at the 2019 ASCRS meeting.
Nutrition a priority for dry eye patients
Here's why John Sheppard, MD, believes nutrition should be the cornerstone of dry eye therapy.
Lid hygiene device improves meibomian gland dysfunction, blepharitis
When used in supplement with other dry eye treatments, patients see improvement
Neuroprotective implant for treatment of glaucoma in phase II trial
Here's the latest innovations at Neurotech Pharmaceuticals, Inc.
SLT is a cost-effective, first-line glaucoma approach
Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD.
Moderate-monovision outcomes see improvement with small aperture IOLs
Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation
Novel compound shows promise for dry eye in proof-of-concept study
Topical drug for the treatment of dry eye disease sees potential
Sustained-release implant promising for long-term IOP reduction
E. Randy Craven, MD, shares results from a phase 1/2 study involving an intracameral bimatoprost sustained-release implant.
Intense pulsed light therapy for the treatment of chalazia
Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions
When to consider corneal cross-linking treatment
Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment
Episode 6: Ophthalmologist's idea sparks invention
In our latest episode, we discuss how an idea can become an invention with Joshua Mali, MD.
Every eye injury on Game of Thrones, ranked
"If you think this has a happy ending, you haven't been paying attention." - Ramsay Bolton.
This woman had *what* living in her eye?!
“THE BEEEEEEEES!”-Nicolas Cage
Orbis educational footprint soars to new heights
Novel telemedicine technology platform allows for real-time mentoring in clinical setting
ASCRS names Stephen H. Speares executive director
The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. “Steve” Speares will serve as the society’s next executive director, according to a prepared statement.
2 Clarke Drive Cranbury, NJ 08512